Advances in pediatric rhabdomyosarcoma characterization and disease model development

Histol Histopathol. 2012 Jan;27(1):13-22. doi: 10.14670/HH-27.13.


Rhabdomyosarcoma (RMS), a form of soft tissue sarcoma, is one of the most common pediatric malignancies. A complex disease with at least three different subtypes, it is characterized by perturbations in a number of signaling pathways and genetic abnormalities. Extensive clinical studies have helped classify these tumors into high and low risk groups to facilitate different treatment regimens. Research into the etiology of the disease has helped uncover numerous potential therapeutic intervention points which can be tested on various animal models of RMS; both genetically modified models and tumor xenograft models. Taken together, there has been a marked increase in the survival rate of RMS patients but the highly invasive, metastatic forms of the disease continue to baffle researchers. This review aims to highlight and summarize some of the most important developments in characterization and in vivo model generation for RMS research, in the last few decades.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Animals
  • Animals, Genetically Modified
  • Child
  • Child, Preschool
  • Disease Models, Animal*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Mice
  • Prognosis
  • Rhabdomyosarcoma / classification*
  • Rhabdomyosarcoma / genetics
  • Rhabdomyosarcoma / metabolism
  • Rhabdomyosarcoma / pathology
  • Rhabdomyosarcoma / therapy
  • Risk Factors
  • Xenograft Model Antitumor Assays